Baxter's Robert Parkinson - CEO Pay

Robert Parkinson, Baxter CEO

Robert Parkinson - Baxter International

Total Compensation: $16M

Details: Parkinson received total compensation of $16 million, down form $17.6 million in 2007. According to SEC filings, Parkinson's compensation "reflects the role he plays in establishing Baxter's strategic agenda and long-range plan, meeting the challenges that arise in the day-to-day operations of a company as large and diverse as Baxter and leading the company in an increasingly challenging global economic environment."

The CEO's base salary came to $1.34 million, restricted stock awards totaled $5.54 million, options came to $5.3 million and cash compensation was $2.7 million. Perks leapt from $153,158 in 2007 to $212.326 in 2008.

Baxter News:
FDA finds 'final link' in heparin case

Baxter's Robert Parkinson - CEO Pay

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

In an interview with Israel's Calcalist, Teva CEO Kåre Schultz shared details of his approach to the company's turnaround.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.